倍他乐克联合参松养心胶囊对阵发性房颤患者P波离散度的影响

目的探讨倍他乐克及参松养心胶囊对阵发性房颤(PAF)患者P波离散度(Pd)的影响。方法将167例PAF患者作为房颤组,随机分为3亚组:A组(倍他乐克组)、B组(参松养心胶囊组)、C组(两药均用组)。以50例无房颤者作为对照组。比较房颤组及无房颤组以及3亚组间治疗前、后Pd水平的差异。结果房颤组Pd高于无房颤组(P<0.01),治疗前A、B、C3亚组Pd差异无显著意义(P>0.05),A、B、C3亚组治疗后Pd较治疗前均有显著降低,差异有显著意义(P<0.05或P<0.01),治疗后A、B亚组间Pd差异无显著意义(P>0.05),C亚组Pd明显低于A、B亚组(P<0.01)。结论倍他乐克、参松养心胶囊联用更有助于预防房颤的复发。

Therapeutic effects of betaloc combined with Shensongyangxin capsule on P wave dispersion in patients with paroxysmal atrial fibrillation

ObjectiveTo investigate the therapeutic effects of betaloc combined with Shensongyangxin capsule on P wave dispersion(Pd) in patients with paroxysmal atrial fibrillation(PAF).Methods167 patients whth PAF were divided into 3 groups randomly,group A(betaloc group),group B(Shensongyangxin capsule group)and group C(both drugs group),and 50 healthy subjects were chosen as control group.ResultsThe Pd in PAF groups was significantly higher than that of control group(P<0.01).There was no significant differences in Pd among three PAF groups(P>0.05).The Pd in three PAF groups was obviously decreased after treatment,compared with that before treatment(P<0.05 or P<0.01).There was no significant difference in Pd after treatment between group A and group B(P>0.05),however,which in group C was significantly lower than that of group A and group B(P<0.01).ConclusionBetaloc combined with Shensongyangxin capsule is helpful to prevent the recurrence of PAF.